This article is based on a presentation by Prof Sergei Ferrari, chair of the Council of Scientific Advisors of the International Osteoporosis Foundation (IOF).

Recent studies clearly show that introducing a bone-forming agent in patients at high or imminent risk of fracture is more effective than antiresorptive agents.

Please sign in to read more